February 2026 Options Now Available For Lam Research (LRCX)

Lam Research (LRCX) trading at $176.37 is the subject of options trade ideas: a sell-to-open $175 put (bid $9.35) would obligate purchase at $175 with a net cost basis of $165.65 and is ~1% out-of-the-money with a 56% chance to expire worthless, equating to a 5.34% return on cash or 44.32% annualized. A covered-call using the $177.50 strike (bid $10.05) against shares bought at $176.37 would cap sale at $177.50 for a 6.34% total return to Feb 2026 if called, is ~1% OTM with a 48% chance to expire worthless and would boost return by 5.70% (47.27% annualized); implied volatility ~50% versus trailing 12-month vol of 48%.

Analysis

Market structure: The immediate winners are income/vol sellers and cash-secured-put buyers willing to be assigned — selling the LRCX Feb‑2026 $175 put collects $9.35 (effective basis $165.65, ~6.0% below spot $176.37) with a 56% theoretical chance of expiring worthless; covered‑call sellers can harvest a 6.34% capped return selling the $177.50 call for $10.05. Dealers and market‑makers collecting premium benefit if realized vol remains ~48–50% (IV≈50%), while directional longs risk being assigned or capped by heavy call issuance. The mechanics favor yield strategies over pure directional exposure in the next 6–12 months unless a large fundamental surprise breaks consensus.

Competitive dynamics & supply/demand: Option selling supply (puts/calls) can compress near‑term realized moves through dealer delta‑hedging — persistent premium selling may mute rallies and create asymmetric downside if dealers unwind. For the semicap theme, LRCX’s exposure to AI data center capex is the key demand driver; any guidance cut of >15–25% in wafer fab spend would materially weaken pricing power and margins. Cross‑asset: a sharp risk‑off would widen credit spreads, push USD stronger and compress semicap multiples; conversely, stronger capex prints would steepen tech outperformance vs. staples.

Risk assessment: Tail risks include (1) swift China export curbs or sanctions reducing LRCX TAM by an incremental 10–25% (stock drop >30%), (2) inventory digestion across fabs leading to a 20–40% revenue revision, and (3) concentrated options gamma causing short squeezes around major expiries. Near‑term (days–weeks) risk centers on earnings/order flow and IV moves; medium (3–9 months) on capex cadence; long (>12 months) on secular AI demand. Hidden dependency: option market positioning and dealer hedging can amplify price moves independent of fundamentals.

Trade implications & contrarian angles: IV≈realized suggests limited edge to naked vol selling unless you size and reserve capital for assignment; the “YieldBoost” annualized figures (44–47%) overstate absolute expected returns because they compress multi‑month risk into a single quote. Consensus misses the tail‑risk asymmetry — many sellers underestimate assignment and guidance risk — so favor small, disciplined income positions and protective hedges rather than aggressive naked short vol. Historical parallels (post‑cycle semicap drawdowns) show rapid 30–50% de‑ratings when end‑market demand softens, so treat positions as tactical (weeks–months) not permanent core holdings.

Key Decisions for Investors

• Sell-to-open LRCX Feb‑2026 $175 cash‑secured put for $9.35: allocate 1–2% of portfolio capital, reserve full $17,500 per contract for assignment, target effective basis $165.65. Risk control: if LRCX trades < $160 before expiration, buy to close or roll down; size so max assignment exposure ≤5% total equity.
• Buy LRCX up to 1–2% portfolio weight and sell Feb‑2026 $177.50 covered calls at $10.05 to harvest a 6.34% capped return; buy back calls if stock rallies >5% intraday or IV falls >8 vol‑points. If assigned, hold or trim to keep net exposure ≤3% portfolio.
• If directional bullish on AI capex with limited downside, buy a 12–18 month call spread (e.g., LRCX Jan‑2027 $200/$300) as a defined‑risk upside play allocating 0.5–1% portfolio; if bearish or seeking protection, purchase 3‑month 10% OTM puts (e.g., Mar ’26 $160 put) to cap downside at ~3–4% cost.
• Relative/value: run a small pair trade long LRCX vs short AMAT (equal dollar) sized 0.5–1% to express conviction that Lam’s exposure to advanced patterning/coating drives superior near‑term ASPs; exit or rebalance after next two earnings releases or a >10% divergence move.